BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 29463510)

  • 1. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
    Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrial appendage occlusion.
    Plicht B; Konorza TF; Kahlert P; Al-Rashid F; Kaelsch H; Jánosi RA; Buck T; Bachmann HS; Siffert W; Heusch G; Erbel R
    JACC Cardiovasc Interv; 2013 Jun; 6(6):606-13. PubMed ID: 23787233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Characterization, and Clinical Impact of Device-Related Thrombus Following Left Atrial Appendage Occlusion in the Prospective Global AMPLATZER Amulet Observational Study.
    Aminian A; Schmidt B; Mazzone P; Berti S; Fischer S; Montorfano M; Lam SCC; Lund J; Asch FM; Gage R; Cruz-Gonzalez I; Omran H; Tarantini G; Nielsen-Kudsk JE
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1003-1014. PubMed ID: 31103540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
    Simard T; Jung RG; Lehenbauer K; Piayda K; Pracoń R; Jackson GG; Flores-Umanzor E; Faroux L; Korsholm K; Chun JKR; Chen S; Maarse M; Montrella K; Chaker Z; Spoon JN; Pastormerlo LE; Meincke F; Sawant AC; Moldovan CM; Qintar M; Aktas MK; Branca L; Radinovic A; Ram P; El-Zein RS; Flautt T; Ding WY; Sayegh B; Benito-González T; Lee OH; Badejoko SO; Paitazoglou C; Karim N; Zaghloul AM; Agrawal H; Kaplan RM; Alli O; Ahmed A; Suradi HS; Knight BP; Alla VM; Panaich SS; Wong T; Bergmann MW; Chothia R; Kim JS; Pérez de Prado A; Bazaz R; Gupta D; Valderrabano M; Sanchez CE; El Chami MF; Mazzone P; Adamo M; Ling F; Wang DD; O'Neill W; Wojakowski W; Pershad A; Berti S; Spoon D; Kawsara A; Jabbour G; Boersma LVA; Schmidt B; Nielsen-Kudsk JE; Rodés-Cabau J; Freixa X; Ellis CR; Fauchier L; Demkow M; Sievert H; Main ML; Hibbert B; Holmes DR; Alkhouli M
    J Am Coll Cardiol; 2021 Jul; 78(4):297-313. PubMed ID: 34294267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
    Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
    Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
    Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
    Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Device-Related Thrombosis Following Left Atrial Appendage Occlusion: A Comparison Between Cardiac Computed Tomography and Transesophageal Echocardiography.
    Korsholm K; Jensen JM; Nørgaard BL; Nielsen-Kudsk JE
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008112. PubMed ID: 31514523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device-associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet.
    Lempereur M; Aminian A; Freixa X; Gafoor S; Kefer J; Tzikas A; Legrand V; Saw J
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):E111-E121. PubMed ID: 28145040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study.
    Cochet H; Iriart X; Sridi S; Camaioni C; Corneloup O; Montaudon M; Laurent F; Selmi W; Renou P; Jalal Z; Thambo JB
    Eur Heart J Cardiovasc Imaging; 2018 Dec; 19(12):1351-1361. PubMed ID: 29415203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
    Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
    EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug.
    Saw J; Tzikas A; Shakir S; Gafoor S; Omran H; Nielsen-Kudsk JE; Kefer J; Aminian A; Berti S; Santoro G; Nietlispach F; Moschovitis A; Cruz-Gonzalez I; Stammen F; Tichelbäcker T; Freixa X; Ibrahim R; Schillinger W; Meier B; Sievert H; Gloekler S
    JACC Cardiovasc Interv; 2017 Feb; 10(4):391-399. PubMed ID: 28231907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
    Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA;
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world survival data of device-related thrombus following left atrial appendage closure: 4-year experience from a single center.
    Bai Y; Xue X; Duenninger E; Muenzel M; Jiang L; Keil T; Fazakas A; Yu J
    Heart Vessels; 2019 Aug; 34(8):1360-1369. PubMed ID: 30820642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombus Formation After Left Atrial Appendage Occlusion With the Amplatzer Amulet Device.
    Sedaghat A; Schrickel JW; Andrié R; Schueler R; Nickenig G; Hammerstingl C
    JACC Clin Electrophysiol; 2017 Jan; 3(1):71-75. PubMed ID: 29759698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
    Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
    Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a Novel Septal Occluder Device for Left Atrial Appendage Closure in Patients With Postsurgical and Postlariat Leaks or Anatomies Unsuitable for Conventional Percutaneous Occlusion.
    Della Rocca DG; Horton RP; Tarantino N; Van Niekerk CJ; Trivedi C; Chen Q; Mohanty S; Anannab A; Murtaza G; Akella K; Gianni C; Bassiouny M; Ahmadian-Tehrani A; Al-Ahmad A; Burkhardt JD; Natale VN; Price M; Gallinghouse GJ; Gibson DN; Lakkireddy D; Di Biase L; Natale A
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009227. PubMed ID: 32942913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.